Showing results (751-760 of 835) with videos related to

Sort By:
Pageof 84
The New England Journal of Medicine|June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell DiseaseHaydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
Blood|September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemiaShannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 2, 2024
Pediatric mental health emergency department visits from 2017 to 2022: A multicenter studyJennifer A Hoffmann, Camille P Carter, Cody S Olsen, et al.
The New England Journal of Medicine|October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastomaAlice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2018
Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic LeukemiaKaren Thudium Mueller, Edward Waldron, Stephan A Grupp, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Nature|September 25, 2024
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remissionZhiliang Bai, Bing Feng, Susan E McClory, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
The Journal of Clinical Investigation|August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesMarco Ruella, David M Barrett, Saad S Kenderian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.
Pageof 84